Linden Capital Promotes Bill Drehkoff to Partner; Todd Van Horn to Principal

Linden Capital Promotes Bill Drehkoff to Partner; Todd Van Horn to Principal

Linden Capital Partners has promoted Bill Drehkoff to Partner and Todd Van Horn to Principal. “Bill and Todd exemplify Linden’s core values especially our commitment to collaboration with our Operating Partners. We are thrilled to recognize their respective achievements and the ongoing value they bring to Linden,” said Brian Miller, Managing Partner.

“Bill’s promotion formally recognizes his significant contributions to our team, our portfolio companies, and our culture,” said Eric Larson, Managing Partner. Mr. Drehkoff re-joined the team at Linden in 2009 after beginning his principal investing career with the founders of Linden Capital Partners at First Chicago Equity Capital over 12 years ago. Mr. Drehkoff’s focus has been on developing platform investments in diagnostics, oral care, life sciences, and specialty distribution. He currently serves on the board of directors of Hycor BioMedical and SeraCare Life Sciences. Following his experience at First Chicago Equity Capital, Mr. Drehkoff earned an MBA from the University of Chicago and was a Principal at The Boston Consulting Group.

Todd Van Horn joined Linden in 2008 and focuses on investments in the medical products, orthopedics, and laboratory services sectors. “Over the last four years, Todd has been a valuable team member and has developed deep sector expertise,” said Managing Partner Tony Davis. Prior to joining Linden, Mr. Van Horn was a Principal and founding member of Healthcare Investment Partners, a private equity partnership focused on healthcare products and related services companies. He began his career in the healthcare investment banking group at Credit Suisse First Boston. Mr. Van Horn currently serves on the board of directors of Strata Pathology Services and CORPAK MedSystems. He holds a Bachelor of Science in Molecular, Cell and Developmental Biology from the UCLA and an MBA from Northwestern.

Linden Capital Partners is focused exclusively on leveraged buyouts in the healthcare and life science industries. Linden’s strategy is based upon four elements: specialization on middle market healthcare and life science companies; integrated private equity and operating expertise; customized value creation programs for each portfolio company; and strategic relationships with large corporations. The firm is located in Chicago, IL (

© 2012 PEPD • Private Equity’s Leading News Magazine • 9-24-12

To search in site, type your keyword and hit enter